Company / Capital Expenditures
Elanco Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$276.0M
FY2025
5-year range
$140.0M / $276.0M
FY2021-FY2025
Trend
+87.8%
vs FY2024
Sector context
#15 of 194
Health Care
What the data says
Among 194 Health Care companies, Elanco is in the top 8% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $99M in FY2017 to $276M in FY2025.
Based on SEC 10-K filings.
$276M in FY2025 with a 5-year CAGR of +15.4%. Top quartile in the Health Care sector.
Improved from $140M to $276M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +17.3%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 194This company $276.0M Sector average $117.5M
▼
+134.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 87.8% year-over-year.
- Ranks #15 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $276.0M | +87.8% |
| FY2024 | $147.0M | +5.0% |
| FY2023 | $140.0M | -18.1% |
| FY2022 | $171.0M | +7.5% |
| FY2021 | $159.0M | +17.8% |
| FY2020 | $135.0M | -3.6% |
| FY2019 | $140.0M | +4.1% |
| FY2018 | $134.5M | +36.4% |
| FY2017 | $98.6M | -10.6% |
| FY2016 | $110.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026